Research and Development strategy
BioGaia's probiotic research is focused on:
-
Scientific documentation of probiotic strains for commercial use and their ability to maintain human health and well-being
-
Strain selection of new, optimal probiotics for targeted health applications
-
Validation of new effective delivery systems for probiotics
-
Demonstration of clinical efficacy and mode of action of L. reuteri and other probiotics in:
-
gastrointestinal health
-
Helicobacter pylori infection
-
inflammation in the digestive tract
-
immune defence
-
gingivitis and dental caries